Association of CTLA-4 gene polymorphisms with sporadic breast cancer risk and clinical features in Han women of Northeast China
- 17 January 2012
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 364 (1-2) , 283-290
Abstract
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is an inhibitory molecule that plays a pivotal role in downregulating T-cell mediated immune responses. To determine the role of CTLA-4 in tumor immunity, and to validate previous results as well, we investigated four tag single nucleotide polymorphisms (SNPs) of CTLA-4 in a relatively large Chinese Han cohort from northeastern China. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) in 581 patients and 566 age-matched controls. Our data indicated that compared with the common genotype and allele of each SNP, the −1722 CC genotype and C allele showed an increased risk of breast cancer (P = 0.030, odds ratio (OR) = 1.457, 95% confidence internal (CI) 1.036–2.051; P = 0.024, OR = 1.214, 95% CI 1.026–1.436, respectively). The −1661 GG genotype and G allele were also associated with an increased risk of breast cancer (P = 0.018, OR = 1.396, 95% CI 1.058–1.843; P = 0.013, OR = 1.353, 95% CI 1.066–1.717, respectively). In the haplotype analysis, the CAAA haplotype showed a higher frequency in cases (P = 0.004), and this association remained significant after correcting the P value for multiple testing. Associations were shown between the SNPs of CTLA-4 and lymph node metastasis, estrogen receptor (ER), progesterone receptor (PR) and P53 statuses. These results indicate that some SNPs in the CTLA-4 gene may affect the risk of breast cancer and show that some SNPs are associated with breast cancer characteristics in Han women in northeastern China.Keywords
This publication has 35 references indexed in Scilit:
- Immune responses to malignanciesJournal of Allergy and Clinical Immunology, 2010
- Breast cancer as a global health concernCancer Epidemiology, 2009
- Targeting cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4)Cancer, 2007
- Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han populationBMC Cancer, 2007
- Regulation of gene expression by alternative untranslated regionsTrends in Genetics, 2006
- Allelic effects on gene regulation at the autoimmunity-predisposing CTLA4 locus: a re-evaluation of the 3′ +6230G>A polymorphismGenes & Immunity, 2005
- Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseNature, 2003
- Molecular Biomarkers for Breast Cancer Prognosis: Coexpression of c-erbB-2 and p53Annals of Surgery, 2001
- CTLA-4 Blockade Enhances the CTL Responses to the p53 Self-Tumor AntigenThe Journal of Immunology, 2001
- Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes.Journal of Experimental Medicine, 1992